Showing results (481-490 of 583) with videos related to

Sort By:
Pageof 59
International Immunology|January 30, 2022
Cancer-derived cholesterol sulfate is a key mediator to prevent tumor infiltration by effector T cellsTakaaki Tatsuguchi, Takehito Uruno, Yuki Sugiura, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 12, 2015
Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302)Eiji Oki, Shoji Tokunaga, Yasunori Emi, et al.
Annals of Surgery|December 24, 2016
Clinicopathological Features of Cervical Esophageal Cancer: Retrospective Analysis of 63 Consecutive Patients Who Underwent Surgical ResectionHiroshi Saeki, Satoshi Tsutsumi, Takafumi Yukaya, et al.
International Journal of Clinical Oncology|January 20, 2026
Molecular analysis of tumor recurrence using established cancer stem cell-line and drug discoveryKiyotaka Nakano, Eiji Oki, Masaki Yamazaki, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|December 25, 2013
Case of early adenosquamous carcinoma of the stomachYasue Kimura, Hiroyuki Matsuda, Hiroshi Saeki, et al.
Oncotarget|March 3, 2016
Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinomaRyuma Tokunaga, Yu Imamura, Kenichi Nakamura, et al.
International Journal of Clinical Oncology|April 30, 2021
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON studyTakeshi Kato, Yoshinori Kagawa, Yasutoshi Kuboki, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 20, 2026
Gut microbiota diversity in patients with ESCC: associations with esophagectomy, the tumor immune microenvironment, and nivolumab responseYuho Ebata, Eiji Oki, Qingjiang Hu, et al.
Surgical Case Reports|December 1, 2016
Distant lymph node metastases caused by esophageal cancer invasion to the lamina propria: a case reportSatoshi Tsutsumi, Hiroshi Saeki, Yuichiro Nakashima, et al.
Med (New York, N.Y.)|June 20, 2024
QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRCHideaki Bando, Daisuke Kotani, Hironaga Satake, et al.
Pageof 59